Recruiting OBSERVATIONAL NCT05787795

Identifying and Characterizing Preclinical MS (DREAM)

Sponsor: Roche-Genentech

Updated 7 times since 2023 Last updated: Nov 12, 2025 Started: Jun 21, 2022 Primary completion: Jun 30, 2032 Completion: Jun 30, 2033

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Multiple Sclerosis and is currently actively recruiting participants. Roche-Genentech leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Recruiting
Mar 2025 — Dec 2025 [monthly]

Recruiting
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Feb 2024 — Jul 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

May 2023 — Feb 2024 [monthly]

Recruiting
Apr 2023 — May 2023 [monthly]

Recruiting

First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Roche-Genentech
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• North Haven, United States